Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hydatidiform Mole × Drug Therapy × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 17 Colorectal Neoplasms 13 Ovarian Neoplasms 11 Lung Neoplasms 10 Neoplasm Metastasis 9 Stomach Neoplasms 8 Nasopharyngeal Carcinoma 8 Neoplasms 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Fallopian Tube Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Ovarian Epithelial 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Multiple Myeloma 2 Melanoma 2

Interventions

merphos 2 Methotrexate 2 Dactinomycin 2 Vacuum Curettage 1 Leucovorin 1 Drug Therapy 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡